Evidence map›Paper›PMID 26368021›Full record

ArticlePLoS genetics2015

Multimer Formation Explains Allelic Suppression of PRDM9 Recombination Hotspots.

Christopher L Baker, Pavlina Petkova, Michael Walker, Petr Flachs, Ondrej Mihola, Zdenek Trachtulec, Petko M Petkov, Kenneth Paigen

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The integrative biology of genetic dominance.Biological reviews of the Cambridge Philosophical Society · 2021
    Review
  10. Pathogenic variants of meiotic double strand break (DSB) formation genes PRDM9 and ANKRD31 in premature ovarian insufficiency.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Christopher L BakerCenter for Genome Dynamics, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Pavlina PetkovaCenter for Genome Dynamics, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Michael WalkerCenter for Genome Dynamics, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Petr FlachsLaboratory of Germ Cell Development, Division BIOCEV, Institute of Molecular Genetics of the Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic.
Ondrej MiholaLaboratory of Germ Cell Development, Division BIOCEV, Institute of Molecular Genetics of the Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic.
Zdenek TrachtulecLaboratory of Germ Cell Development, Division BIOCEV, Institute of Molecular Genetics of the Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic.
Petko M PetkovCenter for Genome Dynamics, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Kenneth PaigenCenter for Genome Dynamics, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Jackson Laboratory · USCzech Academy of Sciences, Institute of Molecular Genetics · CZCzech Academy of Sciences · CZ

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
UNC and PERLEGEN, IncP50GM076468 · NIGMS · JACKSON LABORATORY · PI PETKOV, PETKO M · 2006 to 2015
$31.0M
PRDM9 and Meiotic Regulatory NetworksP01GM099640 · NIGMS · JACKSON LABORATORY · PI PAIGEN, KENNETH · 2013 to 2017
$8.2M
Sex-Specific Regulation of Meiotic Recombination HotspotsR01GM078452 · NIGMS · JACKSON LABORATORY · PI PETKOV, PETKO M · 2007 to 2015
$3.3M
Genomic Organization of Recombination Hot SpotsR01GM078643 · NIGMS · JACKSON LABORATORY · PI PAIGEN, KENNETH · 2006 to 2014
$2.7M
REPRODUCTIVE BIOLOGYT32HD007065 · NICHD · JACKSON LABORATORY · PI BRAUN, ROBERT E · 1985 to 2020
$2.6M
Transacting Genes Regulating Recombination Hotspot ActivitiesR01GM083408 · NIGMS · JACKSON LABORATORY · PI PAIGEN, KENNETH · 2008 to 2014
$2.2M
Genetic Dissection of Quantitative Control of RecombinationF32GM101736 · NIGMS · JACKSON LABORATORY · PI BAKER, CHRISTOPHER LEE · 2012 to 2013
$71k
NCI NIH HHS CA34196NCI NIH HHS P30 CA034196NICHD NIH HHS T32 HD007065NIGMS NIH HHS F32 GM101736NIGMS NIH HHS GM078452NIGMS NIH HHS GM078643NIGMS NIH HHS GM083408NIGMS NIH HHS GM101736NIGMS NIH HHS P01 GM099640NIGMS NIH HHS P50 GM076468NIGMS NIH HHS R01 GM078452NIGMS NIH HHS R01 GM078643NIGMS NIH HHS R01 GM083408PHS HHS GM076468- PROJECT B
6 · The paper itself

Abstract

Genetic recombination during meiosis functions to increase genetic diversity, promotes elimination of deleterious alleles, and helps assure proper segregation of chromatids. Mammalian recombination events are concentrated at specialized sites, termed hotspots, whose locations are determined by PRDM9, a zinc finger DNA-binding histone methyltransferase. Prdm9 is highly polymorphic with most alleles activating their own set of hotspots. In populations exhibiting high frequencies of heterozygosity, questions remain about the influences different alleles have in heterozygous individuals where the two variant forms of PRDM9 typically do not activate equivalent populations of hotspots. We now find that, in addition to activating its own hotspots, the presence of one Prdm9 allele can modify the activity of hotspots activated by the other allele. PRDM9 function is also dosage sensitive; Prdm9+/- heterozygous null mice have reduced numbers and less active hotspots and increased numbers of aberrant germ cells. In mice carrying two Prdm9 alleles, there is allelic competition; the stronger Prdm9 allele can partially or entirely suppress chromatin modification and recombination at hotspots of the weaker allele. In cell cultures, PRDM9 protein variants form functional heteromeric complexes which can bind hotspots sequences. When a heteromeric complex binds at a hotspot of one PRDM9 variant, the other PRDM9 variant, which would otherwise not bind, can still methylate hotspot nucleosomes. We propose that in heterozygous individuals the underlying molecular mechanism of allelic suppression results from formation of PRDM9 heteromers, where the DNA binding activity of one protein variant dominantly directs recombination initiation towards its own hotspots, effectively titrating down recombination by the other protein variant. In natural populations with many heterozygous individuals, allelic competition will influence the recombination landscape.

Indexed as

AllelesRecombination, GeneticAnimalsDNA DamageDosage Compensation, GeneticHEK293 CellsHeterozygoteHistone-Lysine N-MethyltransferaseHistonesHumansMaleMiceMice, KnockoutQuantitative Trait LociHistone-Lysine N-MethyltransferaseHistonesPRDM9 protein, human

Identifiers

PMID26368021
PMCPMC4569383
OpenAlexW2255118273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.